Deqiang Lei Selected Research

Adjuvant Radiotherapy

1/2021

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deqiang Lei Research Topics

Disease

5	Neoplasms (Cancer) 02/2021 - 01/2014
3	Glioma (Gliomas) 01/2021 - 01/2014
1	Hemorrhage 02/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Gliosis 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	galanginIBA 01/2018
1	Conditioned Culture MediaIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Caspase 9IBA 01/2014
1	SurvivinIBA 01/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013

Therapy/Procedure

1	Operative Time 02/2021
1	Length of Stay 02/2021
1	Adjuvant Radiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2014
1	Transplantation 01/2013